Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uterotonic Regimes for PPH Prevention
NCT05467462Completed
- Sponsor
- Bezmialem Vakif University
- Start
- Aug 2022
- Primary completion
- Jan 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carbetocin and tranexamic acid in postpartum hemorrhage (PPH) (4 arms), sponsored by Bezmialem Vakif University. Primary endpoint: Change in hemoglobin and hematocrit concentrations at 24 hours. Started Aug 2022; status: completed.
02
Drugs
carbetocintranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05467462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05467462.